The $3.4 Billion Lesson Pharma Faces in Shelved Drugs
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Are you in your 20s and wondering if a financial advisor is right for you? Learn who should consider seeking professional financial help.
26,867 articlesThousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
BitMine expands its Ethereum hoard to 60,000 ETH worth about $126 million as it enters the Russell 1000 preliminary l...
A new industry view reframes AI as a productivity boost that reshapes tasks, not a job killer, while Gen Z markets fi...
CrowdStrike is set to report Q4 results after the close, with analysts predicting a beat on non-GAAP earnings and rev...
United Airlines outlines a high-oil-price scenario that could push fuel costs well above $20 billion this year. The p...
A proposed US-IRAN 60-day ceasefire would ease oil pressure and lift risk appetite for Bitcoin, but renewed strikes n...
Altria's pricing power has shifted the stock into a retirement fortress, delivering durable cash flow and a high-yiel...
Geopolitical tensions push crypto into a primary-market role, according to Bitwise, as onchain finance gains speed am...
Interloom just raised $16.5 million to convert tacit knowledge into AI-driven workflow tools. The Munich startup says...
A new AI-driven forecast links regulatory resolution, ETF uptake, and RippleNet expansion to a potential XRP surge to...
July could bring a fresh wave of stock gains. This article highlights three stocks likely to lead a rally, with clear...
Bitcoin climbs toward $72,000 as spot ETF inflows continue into a second session, despite rising geopolitical risk in...